Operating Lease, Right-of-Use Asset of CASI Pharmaceuticals, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CASI Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • CASI Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $3,492,000, a 46% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CASI Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,492,000 +$1,100,000 +46% 31 Dec 2024 20-F 31 Mar 2025 2024 FY
Q4 2023 $2,392,000 +$994,000 +71% 31 Dec 2023 20-F 31 Mar 2025 2024 FY
Q4 2022 $1,398,000 -$7,709,000 -85% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q4 2021 $9,107,000 31 Dec 2021 20-F 26 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.